相关实验视频
Updated: May 12, 2026

08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
11.2K
带有氨酸的隐形眼镜持续释放系统:对近视管理新前沿的叙述性审查
Yuhang Liu1,2, Xiaohang Chen1,3, Chenhao Zhu4
1Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610065, China.
Ophthalmology and therapy
|November 18, 2025
概括
与眼滴相比,隐形眼镜药物递送提供了一种优越的近视管理方法. 这种先进的系统增强了氨酸的输送,以更好地控制近视和患者的坚持.
科学领域:
- 眼科和制药科学 眼科和制药科学
- 生物材料和药物输送系统
背景情况:
- 高近视是一个重大的全球健康挑战.
- 传统的低度阿特罗宾眼液具有局限性,包括生物可用性差和患者遵守性.
- 需要先进的药物输送系统来改善近视控制.
研究的目的:
- 审查基于隐形眼镜的药物输送平台,用于近视管理.
- 分析以持续释放系统的形式释放氨酸的隐形眼镜.
- 为了比较这种新的方法与传统的阿特罗平眼滴.
主要方法:
- 全球近视频率和阿特罗宾药理学的系统审查.
- 对氨酸排放式隐形眼镜的设计原则的分析 (材料,加载,释放,评估).
- 临床疗效的评估和与传统方法的比较.
主要成果:
- 隐形眼镜平台提供了改善的生物可用性和患者对眼滴的坚持.
- 从镜片中持续释放的氨酸表明了加强近视控制的潜力.
- 透镜的设计考虑包括材料选择和药物释放动力学.
结论:
- 透视隐形眼镜代表了对近视管理的一种变革性的方法.
- 这种持续释放系统有可能提高治疗疗效和患者坚持治疗.
- 需要进一步的研究来应对技术挑战和安全考虑.
相关概念视频
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

